Summarized by Masters of Longevity from Longevity Docs News.
A year-long trial found no clinical benefit and slightly worse scores on NR.
Key Takeaways
- A randomized trial found NR did not improve early Parkinson's.
- Patients on NR scored slightly worse than placebo on MDS‑UPDRS.
- The one-year, treated‑patient trial was not designed to prove causality.
